Vol 28, No 1 (February 2016): Chinese Journal of Cancer Research

Original Article

A phase I study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with advanced non-small-cell lung cancer
Jun Zhao, Minglei Zhuo, Zhijie Wang, Jianchun Duan, Yuyan Wang, Shuhang Wang, Tongtong An, Meina Wu, Jie Wang
National cancer incidence and mortality in China, 2012
Wanqing Chen, Rongshou Zheng, Tingting Zuo, Hongmei Zeng, Siwei Zhang, Jie He
Heat shock protein inhibitor, quercetin, as a novel adjuvant agent to improve radiofrequency ablation-induced tumor destruction and its molecular mechanism
Wei Yang, Ming Cui, Jungchieh Lee, Wei Gong, Song Wang, Jingjing Fu, Gongxiong Wu, Kun Yan

Review Article

Understanding the molecular pathogenesis and prognostics of bladder cancer: an overview
Ming Zhao, Xiang-Lei He, Xiao-Dong Teng
Molecular aspects of prostate cancer with neuroendocrine differentiation
Qi Li, Connie S. Zhang, Yifen Zhang
The benign mimickers of prostatic acinar adenocarcinoma
Yuqiao Xu, Yingmei Wang, Ru Zhou, Haiyang Li, Hong Cheng, Zhe Wang, Jing Zhang
The update of prostatic ductal adenocarcinoma
Tantan Liu, Yingmei Wang, Ru Zhou, Haiyang Li, Hong Cheng, Jing Zhang
PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer
Zheng Yang, Lu Yu, Zhe Wang
Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology
Tianying Xing, Huiying He
The evolving Gleason grading system
Ni Chen, Qiao Zhou
The pathology of urinary bladder lesions with an inverted growth pattern
Aitao Guo, Aijun Liu, Xiaodong Teng
Intraductal carcinoma of prostate (IDC-P): from obscure to significant
Ni Chen, Qiao Zhou
The pathology of unusual subtypes of prostate cancer
Jing Li, Zhe Wang
Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas
Qiu Rao, Qiu-Yuan Xia, Liang Cheng, Xiao-Jun Zhou